Company intelligence / Profile preview
Royer Biomedical
Frederick, Maryland, United Statesroyerbiomedical.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Royer Biomedical has developed proprietary synthetic polymer platforms capable of delivering a range of pharmaceutical compounds with controlled elution rates. The company holds numerous US and international patents on these technologies. Their focus includes applications in diabetes, orthopedics, cancer therapy, infection control, and biofilm management. No published late-stage clinical results are available as of now.
- Therapeutic areas
- OncologyEndocrinologyInfectious Diseases
- Modalities
- Localized drug delivery systems (polymer matrices)Hydrogel and calcium-based matrices for pharmaceuticalsNovel formulations of existing drugs (anti-infective, anti-neoplastic, analgesic)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Royer Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Royer Biomedical.